SE8803583L - Farmaceutisk komposition - Google Patents

Farmaceutisk komposition

Info

Publication number
SE8803583L
SE8803583L SE8803583A SE8803583A SE8803583L SE 8803583 L SE8803583 L SE 8803583L SE 8803583 A SE8803583 A SE 8803583A SE 8803583 A SE8803583 A SE 8803583A SE 8803583 L SE8803583 L SE 8803583L
Authority
SE
Sweden
Prior art keywords
hrs
exposure
acetyl cysteine
composition
pharmaceutical composition
Prior art date
Application number
SE8803583A
Other languages
Unknown language ( )
English (en)
Other versions
SE462779B (sv
SE8803583D0 (sv
Original Assignee
Lejus Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lejus Medical Ab filed Critical Lejus Medical Ab
Priority to SE8803583A priority Critical patent/SE462779B/sv
Publication of SE8803583D0 publication Critical patent/SE8803583D0/sv
Priority to US07/258,255 priority patent/US4968506A/en
Priority to EP90850133A priority patent/EP0451431A1/en
Publication of SE8803583L publication Critical patent/SE8803583L/sv
Publication of SE462779B publication Critical patent/SE462779B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SE8803583A 1988-10-10 1988-10-10 Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat SE462779B (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE8803583A SE462779B (sv) 1988-10-10 1988-10-10 Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat
US07/258,255 US4968506A (en) 1988-10-10 1988-10-14 Pharmaceutical dosage with core of N-acetyl cystein
EP90850133A EP0451431A1 (en) 1988-10-10 1990-04-06 Pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8803583A SE462779B (sv) 1988-10-10 1988-10-10 Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat

Publications (3)

Publication Number Publication Date
SE8803583D0 SE8803583D0 (sv) 1988-10-10
SE8803583L true SE8803583L (sv) 1990-04-11
SE462779B SE462779B (sv) 1990-09-03

Family

ID=20373568

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8803583A SE462779B (sv) 1988-10-10 1988-10-10 Farmaceutisk komposition innehaallande n-acetylcystein i en kaerna belagd med hydroxipropylmetylcellulosaftalat

Country Status (3)

Country Link
US (1) US4968506A (sv)
EP (1) EP0451431A1 (sv)
SE (1) SE462779B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350741A (en) * 1988-07-30 1994-09-27 Kanji Takada Enteric formulations of physiologically active peptides and proteins
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
ES2077757T5 (es) * 1990-10-19 2001-06-01 Spirig Ag Pharmazeutische Prap Preparacion farmaceutica solida con disolucion rapida que contiene la n-acetilcisteina.
ATE316786T1 (de) * 2000-11-22 2006-02-15 Rxkinetix Inc Behandlung von mukositis
US6623754B2 (en) * 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
US20050118261A1 (en) * 2003-06-12 2005-06-02 Oien Hal J. Compositions and methods of administering doxepin to mucosal tissue
US20050089502A1 (en) * 2003-08-21 2005-04-28 Todd Schansberg Effervescent delivery system
DK1965787T3 (da) * 2005-11-30 2013-06-03 Endo Pharmaceuticals Inc Behandling af xerostomi med en svovlindeholdende antioxidant
FI20060501L (sv) * 2006-05-22 2007-11-23 Biohit Oyj Sammansättning och förfarande för att binda acetaldehyd i magen
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
CN110292569B (zh) * 2019-07-15 2021-11-02 广东人人康药业有限公司 一种乙酰半胱氨酸胶囊及其制备方法
CN113750052B (zh) * 2021-10-19 2022-11-18 桂林华信制药有限公司 一种乙酰半胱氨酸颗粒及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499103A (en) * 1983-03-17 1985-02-12 Merck & Co., Inc. Benzothiazole-2-sulfonamide derivatives for the topical treatment of elevated intraocular pressure
AU574360B2 (en) * 1983-05-13 1988-07-07 Reichert, D. Antisnoring agent
JPS6064912A (ja) * 1983-09-20 1985-04-13 Shiseido Co Ltd パ−マネントウェ−ブ用剤第２剤
IT1170268B (it) * 1983-12-21 1987-06-03 Zambon Spa Uso dell'acetilcisteina per ridurre l'incremento della prolieferazione delle cellule basali dell'epitelio respiratoriotracheo-bronchiale indotto dal fumo di tabacco nei mammiferi
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
CH667590A5 (it) * 1986-07-24 1988-10-31 Inpharzam Int Sa Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .
SE463674B (sv) * 1987-01-15 1991-01-07 Lejus Medical Ab Foerfarande foer behandling i fluidiserad baedd av amfotaera aminosyror och amfotaera derivat av aminosyror

Also Published As

Publication number Publication date
SE462779B (sv) 1990-09-03
US4968506A (en) 1990-11-06
EP0451431A1 (en) 1991-10-16
SE8803583D0 (sv) 1988-10-10

Similar Documents

Publication Publication Date Title
SE8603582D0 (sv) Komposition innehallande l-dopa
SE8803583L (sv) Farmaceutisk komposition
AU634833B2 (en) Pharmaceutical compositions for treating gastrointestinal distress
DK460683D0 (da) Orale mopidamolformer og fremgangsmade til deres fremstilling
CA2339221A1 (en) Extracts of feverfew (tanacetum parthenium) against inflammatory disorders
DK0473333T3 (da) Modificeret polydextrose og fremgangsmåde til fremstilling heraf
DE58901401D1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
PT97785A (pt) Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina
ATE35827T1 (de) Menschliches lymphotoxin und seine derivate, verfahren zu seiner herstellung und dasselbe enthaltende pharmazeutische zusammensetzungen.
HU913010D0 (en) Method for producing inhibitors of calcium ingestion
ATE203907T1 (de) Dermatologische zubereitung zur behandlung von aktinischen keratosen
ATE244578T1 (de) Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit
FR2585572B3 (fr) Nouvelles compositions pharmaceutiques a base d'un sel de l'acide p. chlorophenoxyacetique destinees au traitement des neuropathies et assurant la regeneration nerveuse
BG60101B2 (bg) Метод за получаване на 4-флуор-2-(((4-метокси-2- пиридинил)метил)тионил)-1н-бензимидазол
SE8701077L (sv) Farmaceutisk beredning
DK0821588T3 (da) Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder
DK0612522T3 (da) Blanding og fremgangsmåde til reduktion af risiko for hypotension
AU4434389A (en) Aqueous oral pharmaceutical preparation of diclofenac
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
KR920008035A (ko) 타이로신 유도체 및 그 제조방법
KR900017599A (ko) 종양 치료용 약학 조성물
BR9006746A (pt) Peptideo fisiologicamente ativo e agente regulador do metabolismo de calcio
IE831597L (en) Synergistic antihypertensive pharmaceutical composition.
BG98538U (bg) Средство за анти-нiv терапия

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8803583-7

Effective date: 19920510

Format of ref document f/p: F